Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Methotrexate

5

XVII.e Pneumocystis jiroveci pneumonia

2
Last update : 06/04/2013
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
DMARDs (disease-modifying antirheumatic drugs)
5
Pemetrexed
3

Publications

Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors.
Modern rheumatology 2012 Nov;22;849-58 2012 Nov
Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis.
Rheumatology (Oxford, England) 2012 Dec;51;2120-30 2012 Dec
Pulmonary coinfection by Pneumocystis carinii and Aspegillus fumigatus in a seronegative arthritis patient treated with low-dose methotrexate.
Clinical rheumatology 2004 Dec;23;555-6 2004 Dec
Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma.
Thorax 1991 Dec;46;936-7 1991 Dec
Severe pneumonitis occurring during methotrexate therapy. Re- port of two cases.
Archives of dermatology 1971 Feb;103;194-7 1971 Feb

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies